Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma

被引：60

作者：

Hedstrom, Gustaf ^{[1
]}

Berglund, Mattias

Molin, Daniel

Fischer, Marie

Nilsson, Gunnar

Thunberg, Ulf

Book, Majlis

Sundstrom, Christer

Rosenquist, Richard

Roos, Goran

Erlanson, Martin

Amini, Rose-Marie

Enblad, Gunilla

机构：

[1] Uppsala Univ, Rudbeck Lab, Dept Oncol, S-75145 Uppsala, Sweden

[2] Uppsala Univ, Dept Oncol Radiol & Clin Immunol, S-75145 Uppsala, Sweden

[3] Karolinska Inst, Dept Med, Stockholm, Sweden

[4] Univ Uppsala, Dept Genet & Pathol, S-75105 Uppsala, Sweden

[5] Uppsala Univ, Dept Biosci, Uppsala, Sweden

[6] Umea Univ, Dept Radiat Sci Oncol, Umea, Sweden

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2007年 / 138卷 / 01期

关键词：

mast cells; non-Hodgkin lymphoma; prognostic factors;

D O I：

10.1111/j.1365-2141.2007.06612.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Previous studies indicate that the inflammatory response in diffuse large B-cell lymphomas (DLBCL) is important for the clinical outcome. Mast cells are key regulators in this response; we investigated whether the number of tryptase-positive mast cells is correlated with clinical outcome. Patients with many mast cells had a significantly better event-free survival (EFS) compared to those with few mast cells (P < 0.03 in both germinal centre (GC) and non-GC DLBCL. This supports the idea that the infiltration of mast cells is a reflection of the host inflammatory response and is related to a favourable outcome.

引用

页码：68 / 71

页数：4

共 12 条

[1] CD4+T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome [J].

Ansell, SM ;

Stenson, M ;

Habermann, TM ;

Jelinek, DF ;

Witzig, TE .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (03) :720-726

[2] Tracking CD40 signaling during germinal center development [J].

Basso, K ;

Klein, U ;

Niu, HF ;

Stolovitzky, GA ;

Tu, YH ;

Califano, A ;

Cattoretti, G ;

Dalla-Favera, R .

BLOOD, 2004, 104 (13) :4088-4096

[3] Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells [J].

Dave, SS ;

Wright, G ;

Tan, B ;

Rosenwald, A ;

Gascoyne, RD ;

Chan, WC ;

Fisher, RI ;

Braziel, RM ;

Rimsza, LM ;

Grogan, TM ;

Miller, TP ;

LeBlanc, M ;

Greiner, TC ;

Weisenburger, DD ;

Lynch, JC ;

Vose, J ;

Armitage, JO ;

Smeland, EB ;

Kvaloy, S ;

Holte, H ;

Delabie, J ;

Connors, JM ;

Lansdorp, PM ;

Ouyang, Q ;

Lister, TA ;

Davies, AJ ;

Norton, AJ ;

Muller-Hermelink, HK ;

Ott, G ;

Campo, E ;

Montserrat, E ;

Wilson, WH ;

Jaffe, ES ;

Simon, R ;

Yang, LM ;

Powell, J ;

Zhao, H ;

Goldschmidt, N ;

Chiorazzi, M ;

Staudt, LM .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (21) :2159-2169

[4] Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion [J].

Fischer, Marie ;

Harvima, Ilkka T. ;

Carvalho, Ricardo F. S. ;

Moller, Christine ;

Naukkarinen, Anita ;

Enblad, Gunilla ;

Nilsson, Gunnar .

JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (10) :2748-2756

[5] INDUCTION OF HUMAN IGE SYNTHESIS IN B-CELLS BY MAST-CELLS AND BASOPHILS [J].

GAUCHAT, JF ;

HENCHOZ, S ;

MAZZEI, G ;

AUBRY, JP ;

BRUNNER, T ;

BLASEY, H ;

LIFE, P ;

TALABOT, D ;

FLORESROMO, L ;

THOMPSON, J ;

KISHI, K ;

BUTTERFIELD, J ;

DAHINDEN, C ;

BONNEFOY, JY .

NATURE, 1993, 365 (6444) :340-343

[6] Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray [J].

Hans, CP ;

Weisenburger, DD ;

Greiner, TC ;

Gascoyne, RD ;

Delabie, J ;

Ott, G ;

Müller-Hermelink, HK ;

Campo, E ;

Braziel, RM ;

Jaffe, ES ;

Pan, ZG ;

Farinha, P ;

Smith, LM ;

Falini, B ;

Banham, AH ;

Rosenwald, A ;

Staudt, LM ;

Connors, JM ;

Armitage, JO ;

Chan, WC .

BLOOD, 2004, 103 (01) :275-282

[7]

Jaffe ES., 2001, WHO CLASSIFICATION T

[8] Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma [J].

Molin, D ;

Edström, A ;

Glimelius, I ;

Glimelius, B ;

Nilsson, G ;

Sundström, C ;

Enblad, G .

BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (01) :122-124

[9] Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease [J].

Molin, D ;

Fischer, M ;

Xiang, Z ;

Larsson, U ;

Harvima, I ;

Venge, P ;

Nilsson, K ;

Sundström, C ;

Enblad, G ;

Nilsson, G .

BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (03) :616-623

[10] Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response [J].

Monti, S ;

Savage, KJ ;

Kutok, JL ;

Feuerhake, F ;

Kurtin, P ;

Mihm, M ;

Wu, BY ;

Pasqualucci, L ;

Neuberg, D ;

Aguiar, RCT ;

Dal Cin, P ;

Ladd, C ;

Pinkus, GS ;

Salles, G ;

Harris, NL ;

Dalla-Favera, R ;

Habermann, TM ;

Aster, JC ;

Golub, TR ;

Shipp, MA .

BLOOD, 2005, 105 (05) :1851-1861

← 1 2 →